Tiziana life sciences announces purchase of common shares by chairman and acting ceo

New york, march 17, 2023 (globe newswire) -- tiziana life sciences ltd. (nasdaq: tlsa) (“tiziana” or the “company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announces that it has been notified that gabriele cerrone, its chairman and acting chief executive officer, purchased 25,000 common shares at $0.58 per share, bringing his total holding to 38,640,737 common shares.
TLSA Ratings Summary
TLSA Quant Ranking